Transphorm, Inc. (TGAN)
Jun 20, 2024 - TGAN was delisted (reason: acquired by Renesas)
5.10
+0.34 (7.14%)
Last trade price

Company Description

Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe.

The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications.

The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.

Transphorm, Inc.
Transphorm logo
Country United States
Founded 2007
Industry Semiconductor Equipment & Materials
Sector Technology
Employees 128
CEO Dr. Primit A. Parikh Ph.D.

Contact Details

Address:
75 Castilian Drive
Goleta, California 93117
United States
Phone 805-456-1300
Website transphormusa.com

Stock Details

Ticker Symbol TGAN
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001715768
CUSIP Number 89386L100
ISIN Number US89386L1008
Employer ID 82-1858829
SIC Code 3674

Key Executives

Name Position
Dr. Primit A. Parikh Ph.D. Co-Founder, President, Chief Executive Officer and Director
Cameron McAulay Chief Financial Officer
Dr. Umesh K. Mishra Ph.D. Chairman and Chief Technology Officer
Philip Zuk Senior Vice President of Business Development and Marketing
Tushar Dhayagude Vice President of Worldwide Sales and FAE
Randy Berg Human Resources Leader
Sal Barlett Senior Vice President of Operations

Latest SEC Filings

Date Type Title
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 EFFECT Notice of Effectiveness
Jun 20, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jun 20, 2024 25-NSE Filing